Digital Events

Answers in CME – Replacing Walls With Open Doors: Elevating the Management of Severe Asthma Through Collaborative Care

In this educational activity, Professor Price delivers a series of short lectures that help enhance clinicians’ knowledge of how to effectively manage severe asthma through multidisciplinary techniques. Upon completion of this course, you will be awarded 0.5 CME credits. Click the image below to begin the activity.

ERS Vision – Reducing the use of OCS in the management of asthma

Professors Christopher Brightling, Arnaud Bourdin, David Price and a patient share their views and experiences regarding the benefits and risks of using OCS to manage asthma. Click on the image below to view the whole video.

Professor David Price’s talks at ADVENT, 2019

Oral Corticosteroid-Related Burden in Uncontrolled Persistent Asthma

Expert Insights: Effects of Oral Corticosteroid Use Over a Patient’s Lifetime

Professor David Price discusses the need to minimize oral corticosteroid (OCS) use in patients with severe asthma. Overexposure to OCS can result in several short-term and long-term side effects, including diabetes and osteoporosis.

Expert Insights: Opportunities in the Management of Uncontrolled Persistent Asthma

Dr. William Busse, Dr. Monica Kraft and Professor David Price share their insight on the current opportunities in the management of uncontrolled persistent asthma.

Professor David Price’s interview with Dr. Enrico Heffler, 2019

Professor David Price discusses the International Severe Asthma Registry (ISAR), an initiative by OPRI to create a worldwide database of severe asthma patients.

Rhinology Future Debates, 2017

Professors David Price, Oliver Pfaar and Glenis Scadding talk about whether asthma prevention can be achieved through allergen immunotherapy.

EEACI, 2017

Professor David Price discusses the need for inhaled corticosteroids when treating asthma, the importance of adhering to the prescribed treatment regimen, and how to minimize possible side effects. He also touches on the use of oral corticosteroids during asthma exacerbations.

Professors David Price, Thomas Casale, Claus Bachert and Jean Bousquet share their predictions on the future of asthma treatment.

EEACI, 2016

How can the principles of precision medicine by implemented in primary care, what are the challenges, and how can GPs work with specialists to provide precision medicine? Professor David Price gives his insights.

Dove Medical Press, 2016

Professor David Price provides his expertise on how big database studies in COPD can address questions that cannot be addressed by randomised controlled trials, the benefits and limitations, and how they can be optimised.

European Respiratory Society, 2015

Are randomised controlled trials achieving the results we need for patients? Leading experts consider the value of real-life evidence and whether it can enhance existing guidelines.


Dove Medical Press, 2011

A video abstract of the rapid communication paper “Physicians’ attitudes towards combination therapy with inhaled corticosteroids therapy with inhaled corticosteroids and long-acting β2-agonists: an observational study in UK specialist care” conducted by Professors Mike Thomas, John Haughney and David Price. Presented by Professor Mike Thomas.